Wei Huang

Wei Huang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
XLXiaoyu Liu
Xiaoyu Liu
XXXu Xu
Xu Xu
ZWZhuozhuo Wu
Zhuozhuo Wu
QSQungang Shan
Qungang Shan
ZWZiyin Wang
Ziyin Wang
ZWZhongmin Wang
Zhongmin Wang
Background: The main objective of this study was to analyze the effects of KRAS/TP53 mutation status and tumor sideness on the immune microenvironment of colorectal cancer using integrated scRNA-seq data.Methods: A total of 78 scRNA-seq datasets, comprising 42 treatment-naive colorectal tumors, 13 tumor adjacent tissues and 23 normal mucosa tissues were included. Standardized Seurat procedures were applied to identify cellular components with canonical cell marks. The batch-effect was assessed and corrected using harmony algorithm. The scMetabolism algorithm was used for single-cell metabolic analysis. The results and clinical significance were further validated using immunofluorescent-staining and TCGA-COAD datasets. Immune-infiltration scores of bulk-RNA-seq data were estimated using ssGSEA. The presto-wilcoxauc algorithm was used to identify differentially enriched genes or pathways across different subgroups. Two-sided p-value less than 0.05 was considered statistically significant.Results: We refined the landscape of functional immune cell subtypes, especially T cells and myeloid cells, across normal mucosa, tumor adjacent and tumor tissue. The existence and function of two states of exhausted CD8+ T (Tex) subtypes in colorectal cancer, and FOLR2+ LYVE1+ macrophages indicating unfavorable prognosis in colorectal cancer were identified and validated. The diverse tumor mutation status reshaped the immune cell function and immune checkpoint ligands/receptors (ICLs/ICRs) expression pattern. Importantly, the KRAS/TP53 dual mutations significantly reduced the major energy metabolic functions in immune cells, and promoted the cell-to-cell communications towards immunosuppression in colorectal cancers. The results revealed LAG3, CD24-SIGLEC10 and HBEGF-CD9 pathways as potential therapeutic targets for dual mutant colorectal cancers.Conclusions: We revealed that the immune microenvironment underwent a gradual remodeling with an enrichment of immunosuppressive myeloid cells from normal mucosa to tumor regions in colorectal cancers. Moreover, we revealed the metabolic heterogeneity of tumor-infiltrating immune cells and suggested that the KRAS/TP53 dual mutation may impair antitumor immunity by reducing T and myeloid cell energy metabolism and reshaping cellular interactions toward immunosuppression.

11 March 2022 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
NXNing Xia
Ning Xia
NYNannan Yang
Nannan Yang
QSQungang Shan
Qungang Shan
ZWZiyin Wang
Ziyin Wang
XLXiaoyu Liu
Xiaoyu Liu
ZWZhongmin Wang
Zhongmin Wang
Pancreatic cancer (PC) is one of the most lethal types of cancer due to its asymptomatic nature in the early stages and consequent late diagnosis. Its mortality rate remains high despite advances in treatment strategies, which include a combination of surgical resection and adjuvant therapy. Although these approaches may have a positive effect on prognosis, the development of chemo‐ and radioresistance still poses a significant challenge for successful PC treatment. Heterogeneous nuclear ribonucleoprotein C1/C2 (HNRNPC) and RhoA have been implicated in the regulation of tumour cell proliferation and chemo‐ and radioresistance. Our study aims to investigate the mechanism for HNRNPC regulation of PC radiation resistance via the RhoA pathway. We found that HNRNPC and RhoA mRNA and protein expression levels were significantly higher in PC tissues compared to adjacent non‐tumour tissue. Furthermore, high HNRNPC expression was associated with poor patient prognosis. Using HNRNPC overexpression and siRNA interference, we demonstrated that HNRNPC overexpression promoted radiation resistance in PC cells, while HNRNPC knockdown increased radiosensitivity. However, silencing of RhoA expression was shown to attenuate radiation resistance caused by HNRNPC overexpression. Next, we identified RhoA as a downstream target of HNRNPC and showed that inhibition of the RhoA/ROCK2‐YAP/TAZ pathway led to a reduction in DNA damage repair and radiation resistance. Finally, using both in vitro assays and an in vivo subcutaneous tumour xenograft model, we demonstrated that RhoA inhibition can hinder the activity of cancer‐related fibroblasts and weaken PC radiation resistance. Our study describes a role for HNRNPC and the RhoA/ROCK2‐YAP/TAZ signalling pathways in mediating radiation resistance and provides a potential therapeutic target for improving the treatment of PC.

31 May 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
Tiankuan LiTiankuan Li
Tiankuan Li
WHWei Huang
Wei Huang
ZWZhiyuan Wu
Zhiyuan Wu
YWYong Wang
Yong Wang
QWQingbing Wang
Qingbing Wang
ZWZhongmin Wang
Zhongmin Wang
Background: Tumors at the hepatocaval confluence are difficult to treat, either surgically or ablatively. Methods: A retrospective longitudinal study on patients ineligible for thermal ablation who underwent computed tomography-guided IRE for hepatic tumors at the hepatocaval confluence was conducted. Factors analyzed included patient and tumor characteristics, IRE procedure details, treatment-related complications, and prognosis. Results: Between 2017 and 2021, 21 patients at our institute received percutaneous IRE. Of the 38 lesions, 21 were at the hepatocaval confluence. Complete ablation was achieved in all cases. Local and distant recurrence was observed in 4.8% (1/21) and 42.6% (9/21) of the ablated tumors, respectively. All postcava remained perfused at follow-up, except for 1 (4.8%) hepatic vein near the lesion found to be temporarily occluded and restored within 1 month. The ratio of the maximum diameter of ablation area at 1, 3, and 6 months post procedure compared to that immediately after IRE was 0.68 (0.50–0.84), 0.49 (0.27–0.61), and 0.38 (0.25–0.59), respectively. Progression-free survival of the patients with recurrence was 121 (range, 25–566) days. Four (19.0%) patients died at the end of follow-up with median overall survival of 451.5 (range, 25–716) days. Conclusions: IRE could be a safe and effective treatment for hepatic tumors at the hepatocaval confluence. This article provides valuable prognostic data; further clinical research is needed for better prognosis.

28 October 2025 in Medical Image Analysis
Verified
Journal Article
Closed access
JLJiaxuan Liu
Jiaxuan Liu
HLHaitao Li
Haitao Li
HSHaochen Shi
Haochen Shi
WHWei Huang
Wei Huang
ZWZhongmin Wang
Zhongmin Wang
XCXiaojun Chen
Xiaojun Chen

1 November 2025 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
JLJingjing Liu
Jingjing Liu
XFXiaoyan Fei
Xiaoyan Fei
XLXiaoyu Liu
Xiaoyu Liu
QSQungang Shan
Qungang Shan
SWShenjie Wang
Shenjie Wang
ZWZhongmin Wang
Zhongmin Wang
Background: Postoperative hemorrhage is one of the most critical complications of pancreatic surgery. Pseudoaneurysm formation in postoperative hemorrhage is rare in the clinic. In this study, the safety and efficacy of intravascular intervention for pseudoaneurysm after pancreatic surgery were evaluated, and the risk factors associated with pseudoaneurysm formation after pancreatic surgery were analyzed. The aim of the study was to provide valuable clinical guidance for the effective prevention and treatment of such complications. Methods: A total of 153 patients with delayed pancreatic postoperative hemorrhage treated at Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from April 2015 to April 2024 were retrospectively analyzed, including 76 patients with pseudoaneurysm who were treated with different intravascular interventional treatment methods (coil embolization or covered stent implantation). To evaluate the safety and efficacy of hemostasis, univariate analysis and multiple logistic regression were used to analyze the risk factors for pseudoaneurysm formation. Results: Among the 76 patients with pseudoaneurysm, the majority underwent pancreaticoduodenectomy (n=39; 51.3%), and the most common initial clinical presentation was bleeding through the surgical drainage tube (n=36, 47.4%). The main vessels invaded were the common hepatic artery and branches (n=25, 32.9%), the superior mesenteric artery and branches (n=22, 28.9%), the gastroduodenal artery and branches (n=12, 15.8%), and the splenic artery (n=11, 14.5%). The technical success rate of both coil embolization and covered stent implantation was 100%. The survival rate during hospitalization was 90.8%. None of the survivors experienced rebleeding at the treatment site during follow-up. The univariate analysis identified preoperative total bilirubin >17.1 µmol/L, preoperative and postoperative albumin <30 g/L, postoperative hemoglobin 6 hours, pancreatic fistula, and abdominal infection as risk factors of postoperative pseudoaneurysm formation (P<0.05). Multivariate logistic regression analysis confirmed that postoperative albumin <30 g/L, pancreatic fistula, and abdominal infection were independent risk factors for postoperative pseudoaneurysm formation (P<0.05). Conclusions: Endovascular intervention is a safe and effective method for the treatment of pseudoaneurysm caused by delayed hemorrhage after pancreatic surgery. In this study, postoperative albumin <30 g/L, pancreatic fistula, and intraperitoneal infection were identified as independent risk factors for pseudoaneurysm formation after pancreatic surgery. Monitoring the levels of serum albumin and hemoglobin after surgery, early detection of pancreatic fistula, and early use of sensitive antibiotics to control abdominal infection may reduce the occurrence of postoperative pancreatic pseudoaneurysm, decrease the risk of hemorrhage, and improve prognosis.

23 March 2026 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
YXYin Xu
Yin Xu
XFXiaoyan Fei
Xiaoyan Fei
YCYingjie Chen
Yingjie Chen
NYNannan Yang
Nannan Yang
BJBinbin Ji
Binbin Ji
ZWZhongmin Wang
Zhongmin Wang
Airway stents have been widely employed for the palliation of malignant airway stenosis (MAS) and airway–esophageal fistula (AEF). The factors that i